Influence of doxorubicin on fluconazole susceptibility and efflux pump gene expression of Candida dubliniensis

References

• Viscoli C, Girmenia C, Marinus A, . Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071–1079.
   PubMed Web of Science ®Google Scholar
• Vogel M, Hartmann T, Koberle M, . Rifampicin induces MDR1 expression in Candida albicans. J Antimicrob Chemother 2008; 61: 541–547.
   Google Scholar
• Kofla G, Turner V, Schulz B, . Doxorubicin induces drug efflux pumps in Candida albicans. Med Mycol 2011; 49: 132–142.
   PubMed Web of Science ®Google Scholar
• Karababa M, Coste AT, Rognon B, Bille J, Sanglard D. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 2004; 48: 3064–3079.
   PubMed Web of Science ®Google Scholar
• de Micheli M, Bille J, Schueller C, Sanglard D. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 2002; 43: 1197–1214.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
   PubMed Web of Science ®Google Scholar
• Kibbler CC, Seaton S, Barnes RA, . Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18–24.
   PubMed Web of Science ®Google Scholar
• Manfredi M, McCullough MJ, Al-Karaawi ZM, Hurel SJ, Porter SR. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol 2002; 17: 181–185.
   Google Scholar
• Peltroche-Llacsahuanga H, Dohmen H, Haase G. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients. Mycoses 2002; 45: 15–18.
   PubMed Web of Science ®Google Scholar
• Davies AN, Brailsford S, Broadley K, Beighton D. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 2002; 17: 79–84.
   PubMedGoogle Scholar
• Dahiya MC, Redding SW, Dahiya RS, . Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 57: 79–83.
   PubMed Web of Science ®Google Scholar
• Dougherty PF, Yotter DW, Matthews TR. Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents. Antimicrob Agents Chemother 1977; 11: 225–228.
   Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
   PubMed Web of Science ®Google Scholar
• Moran G, Sullivan D, Morschhäuser J, Coleman D. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob Agents Chemother 2002; 46: 2829–2841.
   Google Scholar
• Perea S, Lopez-Ribot JL, Wickes BL, . Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 2002; 46: 1695–1703.
   Google Scholar
• Pinjon E, Moran GP, Jackson CJ, . Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 2003; 47: 2424–2437.
   PubMed Web of Science ®Google Scholar
• Moran GP, Sanglard D, Donnelly SM, . Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819–1830.
   PubMed Web of Science ®Google Scholar
• Pinjon E, Jackson CJ, Kelly SL, . Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob Agents Chemother 2005; 49: 1312–1318.
   PubMed Web of Science ®Google Scholar
• Coleman DC, Moran GP, McManus BA, Sullivan DJ. Mechanisms of antifungal drug resistance in Candida dubliniensis. Future Microbiol 2010; 5: 935–949.
   Google Scholar
• Sanger Institute. Candida dubliniensis sequencing. www.sanger.ac.uk/sequencing/Candida/dubliniensis/.
   Google Scholar
• Krishnamurthy S, Gupta V, Snehlata P, Prasad R. Characterisation of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family. FEMS Microbiol Lett 1998; 158: 69–74.
   Google Scholar